TY - JOUR
T1 - High prevalence of proximal and distal gastroesophageal reflux disease in advanced COPD
AU - Kempainen, Robert R.
AU - Savik, Kay
AU - Whelan, Timothy P.
AU - Dunitz, Jordan M
AU - Herrington, Cynthia S.
AU - Billings, Joanne L
PY - 2007/6
Y1 - 2007/6
N2 - Background: Gastroesophageal reflux disease (GERD) is common in a variety of chronic respiratory diseases, but little is known about GERD in the setting of COPD. The aims of this study were to determine the prevalence, presentation, and predictors of GERD based on proximal and distal esophageal pH monitoring in patients with severe COPD. Methods: Forty-one COPD patients with a mean FEV 1 of 24% of predicted underwent dual-probe 24-h esophageal pH monitoring, and 1 patient underwent esophagogastroduodenoscopy. Results: The prevalence of GERD was 57%. Elevated distal and proximal reflux were present in 41% and 46% of patients undergoing esophageal pH studies, respectively. Fifteen percent of these patients had abnormal proximal reflux despite having normal distal probe results. Most patients with GERD were not receiving acid blockers at the time of their referral, and only one third reported heartburn and/or acid regurgitation during the pH study. Only higher body mass index was predictive of reflux on regression analysis (odds ratio, 1.2; 95% confidence interval, 1.0 to 1.5; p = 0.05). Conclusions: GERD is common in advanced COPD. Patients are often asymptomatic and have a relatively high prevalence of isolated abnormal proximal reflux. Dual-probe monitoring is therefore well suited for detecting GERD in patients with advanced COPD.
AB - Background: Gastroesophageal reflux disease (GERD) is common in a variety of chronic respiratory diseases, but little is known about GERD in the setting of COPD. The aims of this study were to determine the prevalence, presentation, and predictors of GERD based on proximal and distal esophageal pH monitoring in patients with severe COPD. Methods: Forty-one COPD patients with a mean FEV 1 of 24% of predicted underwent dual-probe 24-h esophageal pH monitoring, and 1 patient underwent esophagogastroduodenoscopy. Results: The prevalence of GERD was 57%. Elevated distal and proximal reflux were present in 41% and 46% of patients undergoing esophageal pH studies, respectively. Fifteen percent of these patients had abnormal proximal reflux despite having normal distal probe results. Most patients with GERD were not receiving acid blockers at the time of their referral, and only one third reported heartburn and/or acid regurgitation during the pH study. Only higher body mass index was predictive of reflux on regression analysis (odds ratio, 1.2; 95% confidence interval, 1.0 to 1.5; p = 0.05). Conclusions: GERD is common in advanced COPD. Patients are often asymptomatic and have a relatively high prevalence of isolated abnormal proximal reflux. Dual-probe monitoring is therefore well suited for detecting GERD in patients with advanced COPD.
KW - Acid blockers
KW - Aspiration
KW - COPD
KW - Gastroesophageal reflux disease
UR - http://www.scopus.com/inward/record.url?scp=34250893852&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34250893852&partnerID=8YFLogxK
U2 - 10.1378/chest.06-2264
DO - 10.1378/chest.06-2264
M3 - Article
C2 - 17400682
AN - SCOPUS:34250893852
SN - 0012-3692
VL - 131
SP - 1666
EP - 1671
JO - CHEST
JF - CHEST
IS - 6
ER -